Since plasma adiponectin levels are decreased in those with obesity, insulin resistance, or type 2 diabetes [21], adiponectin level is considered to be a biomarker of the metabolic syndrome [22]. The gene discussed is ADIPOQ; the disease is type 2 diabetes mellitus.